Skip to main content
Top
Published in: Current Reviews in Musculoskeletal Medicine 4/2015

01-12-2015 | Orthopedic Oncology: New Concepts and Techniques (JH Schwab, Section Editor)

Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art

Authors: Peter S. Rose, Jonathan M. Morris

Published in: Current Reviews in Musculoskeletal Medicine | Issue 4/2015

Login to get access

Abstract

The field of cryosurgery began nearly 40 years ago with the open application of liquid nitrogen to ablate tumors. Recent developments in imaging and cryoprobe technology allow for percutaneous ablation of tumors. Computed tomography (CT)-guided cryoablation has particular use in treating musculoskeletal neoplasms because of the ability to image the lethal ice zone around both bone and soft tissue structures. This manuscript will review the development, indications, and results of cryoablation as applied to musculoskeletal neoplasms. This technique holds promise for the treatment of benign conditions as well as the palliation and durable treatment of musculoskeletal metastases; it is not commonly indicated in the curative treatment of primary malignant bone or soft tissue sarcomas.
Literature
1.
go back to reference Marcove RC, Miller TR. The treatment of primary and metastatic localized bone tumors by cryosurgery. Surg Clin N Am. 1969;49:421–30.PubMed Marcove RC, Miller TR. The treatment of primary and metastatic localized bone tumors by cryosurgery. Surg Clin N Am. 1969;49:421–30.PubMed
2.
go back to reference Meller I, Weinbroum A, Bickels J, et al. Fiftenn years of bone tumor cryosurgery: a single center experience of 440 procedures and long-term follow-up. Eur J Surg Oncol. 2008;34:921–7.CrossRefPubMed Meller I, Weinbroum A, Bickels J, et al. Fiftenn years of bone tumor cryosurgery: a single center experience of 440 procedures and long-term follow-up. Eur J Surg Oncol. 2008;34:921–7.CrossRefPubMed
3.
go back to reference Veth R, Schreuder B, van Beem H, et al. Cryosurgery in aggressive, benign, and low-grade malignant bone tumors. Lancet Oncol. 2005;6:25–34.CrossRefPubMed Veth R, Schreuder B, van Beem H, et al. Cryosurgery in aggressive, benign, and low-grade malignant bone tumors. Lancet Oncol. 2005;6:25–34.CrossRefPubMed
5.•
go back to reference Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skelet Radiol. 2009;38:835–9. While published in 2009, this article remains current and outlines the rationale and indications for considering cryoablation of musculeoskeletal metastatic disease.CrossRef Callstrom MR, Kurup AN. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skelet Radiol. 2009;38:835–9. While published in 2009, this article remains current and outlines the rationale and indications for considering cryoablation of musculeoskeletal metastatic disease.CrossRef
6.
go back to reference de Vries J, Oldhoff J, Handers HN. Cryosurgical treatment of sacrococcygeal chordoma. Report of 4 cases. Cancer. 1986;58:2348–54.CrossRefPubMed de Vries J, Oldhoff J, Handers HN. Cryosurgical treatment of sacrococcygeal chordoma. Report of 4 cases. Cancer. 1986;58:2348–54.CrossRefPubMed
7.
go back to reference Meftah M, Schult P, Henshaw RM. Long-term results of intralesional curettage and cryosurgery for treatment of low-grade chondrosarcoma. J Bone Joint Surg Am. 2013;95:1358–64.CrossRefPubMed Meftah M, Schult P, Henshaw RM. Long-term results of intralesional curettage and cryosurgery for treatment of low-grade chondrosarcoma. J Bone Joint Surg Am. 2013;95:1358–64.CrossRefPubMed
9.
go back to reference Pritsch T, Bickels J, Wu CC, et al. The risk for fractures after curettage and cryosurgery around the knee. Clin Orthop Relat Res. 2007;458:159–67.PubMed Pritsch T, Bickels J, Wu CC, et al. The risk for fractures after curettage and cryosurgery around the knee. Clin Orthop Relat Res. 2007;458:159–67.PubMed
10.
go back to reference Coupal TM, Mallinson PI, Munk PL, et al. CT-guided percutaneous cryoablation for osteoid osteoma: initial experience in adults. AJR Am J Roentgenol. 2014;202:1136–9.CrossRefPubMed Coupal TM, Mallinson PI, Munk PL, et al. CT-guided percutaneous cryoablation for osteoid osteoma: initial experience in adults. AJR Am J Roentgenol. 2014;202:1136–9.CrossRefPubMed
11.
go back to reference Wu B, Xiao X, Zhang X, Zhao L, Carrino JA. CT-guided percutaneous cryoablation of osteoid osteoma in children: an initial study. Skelet Radiol. 2011;40:1303–10.CrossRef Wu B, Xiao X, Zhang X, Zhao L, Carrino JA. CT-guided percutaneous cryoablation of osteoid osteoma in children: an initial study. Skelet Radiol. 2011;40:1303–10.CrossRef
12.
go back to reference Walczak BE, Rose PS. Desmoid: the role of local therapy in an era of systemic options. Curr Treat Options Oncol. 2013;14:465–73.CrossRefPubMed Walczak BE, Rose PS. Desmoid: the role of local therapy in an era of systemic options. Curr Treat Options Oncol. 2013;14:465–73.CrossRefPubMed
13.
go back to reference Havez M, Lippa N, Al-Ammari S, et al. Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol. 2014;37:1500–6.CrossRefPubMed Havez M, Lippa N, Al-Ammari S, et al. Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol. 2014;37:1500–6.CrossRefPubMed
14.
go back to reference Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skelet Radiol. 2010;39:175–82.CrossRef Kujak JL, Liu PT, Johnson GB, Callstrom MR. Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skelet Radiol. 2010;39:175–82.CrossRef
15.
go back to reference Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol. 2007;10:120–31.CrossRefPubMed Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol. 2007;10:120–31.CrossRefPubMed
16.•
go back to reference Castaneda Rodriguez WRC, Callstrom MR. Effective pain palliation and prevention of fracture for axial-loading skeletal metastases using combined cryoablation and cementoplasty. Tech Vasc Interv Radiol. 2011;14:160–9. This recent study provides case examples, indications, and outcomes of patients treated with combined cryoablation and cementation of axial lytic bone lesions.CrossRefPubMed Castaneda Rodriguez WRC, Callstrom MR. Effective pain palliation and prevention of fracture for axial-loading skeletal metastases using combined cryoablation and cementoplasty. Tech Vasc Interv Radiol. 2011;14:160–9. This recent study provides case examples, indications, and outcomes of patients treated with combined cryoablation and cementation of axial lytic bone lesions.CrossRefPubMed
17.
go back to reference Alt AL, Boorjian SA, Lohse CM, et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer. 2011;117:2873–82.CrossRefPubMed Alt AL, Boorjian SA, Lohse CM, et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer. 2011;117:2873–82.CrossRefPubMed
18.
go back to reference Rubin P, Brasacchio R, Katz A. Solitary metastases: illusion versus reality. Semin Radiat Oncol. 2006;16:120–30.CrossRefPubMed Rubin P, Brasacchio R, Katz A. Solitary metastases: illusion versus reality. Semin Radiat Oncol. 2006;16:120–30.CrossRefPubMed
19.•
go back to reference Deschamps F, Farouil G, Ternes N, et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients? Eur Radiol. 2014;24:1971–80. This article provides a large cohort of over 100 ablated lesions in 89 patients and provides multivariate modeling of factors associated with success.CrossRefPubMed Deschamps F, Farouil G, Ternes N, et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients? Eur Radiol. 2014;24:1971–80. This article provides a large cohort of over 100 ablated lesions in 89 patients and provides multivariate modeling of factors associated with success.CrossRefPubMed
20.•
go back to reference McMenomy BP, Kurup AN, Johnson GB, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013;24:207–13. This recent publication demonstrates excellent local control (87%) at median 21 month follow-up of 52 patients with oligometastatic disease to bone and soft tissues.CrossRefPubMed McMenomy BP, Kurup AN, Johnson GB, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013;24:207–13. This recent publication demonstrates excellent local control (87%) at median 21 month follow-up of 52 patients with oligometastatic disease to bone and soft tissues.CrossRefPubMed
21.
go back to reference Masala S, Schillaci O, Bartolucci AD, et al. Metabolic and clinical assessment of efficacy of cryoablation on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analog scale (VAS): initial experience. Skelet Radiol. 2011;40:159–65.CrossRef Masala S, Schillaci O, Bartolucci AD, et al. Metabolic and clinical assessment of efficacy of cryoablation on skeletal masses by 18F-FDG positron emission tomography/computed tomography (PET/CT) and visual analog scale (VAS): initial experience. Skelet Radiol. 2011;40:159–65.CrossRef
22.
go back to reference Filippiadis DK, Tutton S, Mazioti A, Kelekis A. Percutaneous image-guided ablation of bone and sfot tissue tumours: a review of available techniques and protective measures. Insights Imaging. 2014;5:339–46.PubMedCentralCrossRefPubMed Filippiadis DK, Tutton S, Mazioti A, Kelekis A. Percutaneous image-guided ablation of bone and sfot tissue tumours: a review of available techniques and protective measures. Insights Imaging. 2014;5:339–46.PubMedCentralCrossRefPubMed
23.
go back to reference Kurup AN, Woodrum DA, Morris JM, et al. Cryoablation of recurrent sacrococcygeal tumors. J Vasc Interv Radiol. 2012;23:1070–5.CrossRefPubMed Kurup AN, Woodrum DA, Morris JM, et al. Cryoablation of recurrent sacrococcygeal tumors. J Vasc Interv Radiol. 2012;23:1070–5.CrossRefPubMed
24.
go back to reference Kurup AN, Morris JM, Boon AJ, et al. Motor evoked potentials monitoring during cryoablation of musculoskeletal tumors. J Vasc Interv Radiol. 2014;25:1657–64.CrossRefPubMed Kurup AN, Morris JM, Boon AJ, et al. Motor evoked potentials monitoring during cryoablation of musculoskeletal tumors. J Vasc Interv Radiol. 2014;25:1657–64.CrossRefPubMed
Metadata
Title
Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art
Authors
Peter S. Rose
Jonathan M. Morris
Publication date
01-12-2015
Publisher
Springer US
Published in
Current Reviews in Musculoskeletal Medicine / Issue 4/2015
Electronic ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-015-9307-6

Other articles of this Issue 4/2015

Current Reviews in Musculoskeletal Medicine 4/2015 Go to the issue

Revision Knee Arthroplasty (R Rossi, Section Editor)

The use of spacers (static and mobile) in infection knee arthroplasty

Revision Knee Arthroplasty (R. Rossi, Section Editor)

Painful knee arthroplasty: current practice

Cartilage Repair Techniques in the Knee (A Dhawan, Section Editor)

Osteochondral allograft

Orthopedic Oncology: New Concepts and Techniques (JH Schwab, Section Editor)

Chordoma: an update on the pathophysiology and molecular mechanisms

Revision Knee Arthroplasty (R Rossi, Section Editor)

The role of offset stems in revision knee arthroplasty

Cartilage Repair Techniques in the Knee (A Dhawan, Section Editor)

Surgical treatment for osteochondritis dessicans of the knee